Elixiron Immunotherapeutics (hong Kong) Ltd.

This study tests a new drug called EI-001 in 45 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The drug works by calming the immune system to reduce inflammation that leads to pigment loss. Participants will receive either EI-001 or a placeb…

This study tests a new drug called EI-1071 in 15 people with mild to severe Alzheimer's disease. The main goal is to see if the drug is safe and tolerable over 4 weeks, and to measure its effect on brain inflammation using PET scans. Participants must have stable Alzheimer's symp…